Colorectal Cancer Screening Blood Test Approved by FDA
-
By
-
Kathryn Wighton
-
July 27, 2026
-
2 min
By
Kathryn Wighton
July 27, 2026
In a Swedish population-based screening cohort, the blood-based risk model had higher short-term sensitivity for clinically significant prostate cancer than prostate-specific antigen testing, with similar specificity.
June 25, 2026
Risk-based management may reduce unnecessary excisions in selected patients with CIN 2.
June 26, 2026
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026